NEXTHERA CAPITAL LP - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 93 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 3.64 and the average weighting 0.7%.

Quarter-by-quarter ownership
NEXTHERA CAPITAL LP ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$6,082,000
+404.7%
242,300
+384.6%
1.56%
+198.1%
Q2 2017$1,205,000
-58.3%
50,000
-66.7%
0.52%
-64.4%
Q1 2017$2,888,000
+87.5%
150,000
+50.0%
1.47%
+63.2%
Q4 2016$1,540,000100,0000.90%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
AIGH Capital Management LLC 2,339,107$10,502,0003.20%
Telemetry Investments, L.L.C. 262,279$1,178,0001.52%
Bruce & Co., Inc. 1,443,312$6,480,0001.30%
Omega Fund Management, LLC 1,971,241$8,851,0001.25%
Worth Venture Partners, LLC 556,832$2,500,0001.24%
Abingworth LLP 1,041,131$4,654,0001.13%
1492 Capital Management LLC 491,033$2,205,0001.09%
CM Management, LLC 300,000$1,347,0001.02%
Trellus Management Company, LLC 295,000$1,325,0000.88%
GENERAL AMERICAN INVESTORS CO INC 1,306,919$5,868,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders